Current Investing Position
Canaan Partners General Partner
Investment Range
$250K - $20.0M
Sweet Spot
$10.0M
Investments On Record
47
Current Fund Size
$800M
Brent Ahrens is on these Sector & Stage Rankings
Brent Ahrens's Investments On Record (16)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Greywolf Therapeutics | Series BMay 2024$50M Series BJan 2023$49M Series AJan 2020$3M Series AFeb 2019$13M | $120M |
illumicell AI | Pre SeedNov 2023$300K | $300K |
Relievant Medsystems | Series FOct 2020$70M  Series EJun 2018$58M Series DOct 2016$36M Series DMar 2012$30M Series CJul 2009$20M Series BOct 2006$5M | $220M |
EndoGastric Solutions | Series IJun 2018$41M Series UnknownDec 2015$50M Series GMay 2014$30M Series UnknownJun 2012$13M Series UnknownApr 2012$2M Series GMar 2012$11M Series FAug 2010$30M | $230M |
Unchained Labs | Series DMar 2018$17M Series CJun 2017$13M Series BFeb 2016$25M Series AFeb 2015$25M  | $80M |
Iterum Therapeutics | Series BMay 2017$65M Series AMar 2016$40M | $110M |
Abyrx | Series UnknownDec 2016$10M | $10M |
Minimally invasive devices | Series CNov 2015$14M Debt FinancingJun 2014$6M Series BJun 2013$3M Series BMar 2013$9M | $32M |
Investors who invest with Brent Ahrens